A cli nical trial is any research project that assig ns hum an subjects prospective ly to co mp ar iso n gro ups and co mpares the relationships bet ween a medica l interven tion and a he alth outcome. The CO NSO RT (Conso lidated St andards of Rep orting Trials) guidelines were es ta blished to assist investigators in ac hieving hig h-qua lity research design and reporting I but, un fortun ately, ma ny clinica l trials remain un pub lished.
So me researchers fail to publish because of negat ive or inconclusive outco mes; other investigators have give n up co ntro l. and a fund ing organization has refused publica tion. Failu re to dissem inate clini cal tria l infor mation (reg ardless of outco me) has ca used co nsiderable co nce rn within the sc ientific co m munity, partic ularly amo ng edi to rs of me dical j ou rnal s."
Th is pro blem is both ethica l and practi ca l. By definiti on . clinica l trials involve patient vo luntee rs. In ma ny ca ses, patients have acc epted conside rab le inconven ience, discom fort , and risk in choosing to participate in clinica l studies. Often, they are aware that they wi ll receive no perso nal benefit fro m the study. but they have vo lunteered to ass ist med ical sc ience in hel ping future pa tie nts. Clinical trial vo lunteers have a right to know the outco mes of the studies in which they have par ticipated . In addition . we sho uld be a ble to ass ure them that physici ans will have access to whatever informati on the study has ge nerated, regardl ess o f its conclusions .
T he Internation al Co mmittee of Medica l Journal Editors has issued a stateme nt including the op inio n that every cl inic al trial has to be reg istered in a co mplete publi c database in orde r for an article about that trial to be accepted for review by a medical j ournal." I be lieve this opinion is correct and should be endorse d by all med ical j ourna ls.
Trial registries are read ily access ible on the Intern et.' For examp le, the Web site C linica ITrials.gov makes such inform ation ava ilab le for both ph ysici ans and patie nts. Registration of Phase I trials (pharmacok inet ics or drug toxicity) and Ph ase II (dosing) trials is recom mended , but Phase III trial registration sho uld be mand atory.
Pha se III trials are designed to help de termine clinical practice. Ev ide nce fro m every such proj ect is poten tially valuable. Eve n equivocal or negative results provide the scientific co mm unity with important inform at ion abo ut what not to do , as we ll as w hat not to spend time or money researching aga in (at leas t using the same ex perime ntal de sign).
Registering a clin ical trial on the ClinicalTrials.gov Web site is ea sy. Investigators 
